Ernest Mui
Overview
Explore the profile of Ernest Mui including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
1055
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Felin M, Wang K, Raggi C, Moreira A, Pandey A, Grose A, et al.
Curr Pediatr Rep
. 2023 Sep;
10(3):109-124.
PMID: 37744780
Purpose Of Review: Review comprehensive data on rates of toxoplasmosis in Panama and Colombia. Recent Findings: Samples and data sets from Panama and Colombia, that facilitated estimates regarding seroprevalence of...
2.
Tibbo A, Hartley A, Vasan R, Shaw R, Galbraith L, Mui E, et al.
Br J Cancer
. 2023 Mar;
128(11):1991-1999.
PMID: 36991255
Background: Prostate cancer is the most common cancer in men in the developed world, with most deaths caused by advanced and metastatic disease which has no curative options. Here, we...
3.
Felin M, Wang K, Moreira A, Grose A, Leahy K, Zhou Y, et al.
Curr Pediatr Rep
. 2023 Mar;
10(3):93-108.
PMID: 36969368
Purpose Of Review: Review work to create and evaluate educational materials that could serve as a primary prevention strategy to help both providers and patients in Panama, Colombia, and the...
4.
Felin M, Wang K, Moreira A, Grose A, Leahy K, Zhou Y, et al.
Curr Pediatr Rep
. 2022 Aug;
10(3):57-92.
PMID: 36034212
Purpose Of Review: Review building of programs to eliminate infections. Recent Findings: Morbidity and mortality from toxoplasmosis led to programs in USA, Panama, and Colombia to facilitate understanding, treatment, prevention,...
5.
Felin M, Wang K, Moreira A, Grose A, Leahy K, Zhou Y, et al.
Curr Pediatr Rep
. 2022 Aug;
10(3):125-154.
PMID: 35991908
Purpose Of Review: Review international efforts to build a global public health initiative focused on toxoplasmosis with spillover benefits to save lives, sight, cognition and motor function benefiting maternal and...
6.
Rushworth L, Loveridge C, Salji M, MacLeod M, Mui E, Sumpton D, et al.
BJU Int
. 2022 Jul;
131(2):236-243.
PMID: 35844167
Objectives: To test for evidence of statin-mediated effects in patients with castration-resistant prostate cancer (CRPC) as post-diagnosis use of statins in patients with prostate cancer is associated with favourable survival...
7.
Patel R, Ford C, Rodgers L, Rushworth L, Fleming J, Mui E, et al.
Cancer Res
. 2022 Jun;
82(14):2565-2575.
PMID: 35675421
Significance: Enhanced creatine uptake drives prostate cancer progression and confers a metabolic vulnerability to treatment with the creatine analog cyclocreatine.
8.
Blomme A, Peter C, Mui E, Blanco G, An N, Mason L, et al.
EMBO Mol Med
. 2022 Jan;
14(3):e14764.
PMID: 35014179
Despite the clinical benefit of androgen-deprivation therapy (ADT), the majority of patients with advanced prostate cancer (PCa) ultimately develop lethal castration-resistant prostate cancer (CRPC). In this study, we identified thioesterase...
9.
Galbraith L, Mui E, Nixon C, Hedley A, Strachan D, Mackay G, et al.
Oncogene
. 2021 Mar;
40(13):2355-2366.
PMID: 33654198
Peroxisome Proliferator-Activated Receptor Gamma (PPARG) is one of the three members of the PPAR family of transcription factors. Besides its roles in adipocyte differentiation and lipid metabolism, we recently demonstrated...
10.
Malviya G, Patel R, Salji M, Martinez R, Repiscak P, Mui E, et al.
EJNMMI Res
. 2020 Nov;
10(1):143.
PMID: 33237350
Background: Prostate cancer is highly prevalent worldwide. Androgen deprivation therapy (ADT) remains the treatment of choice for incurable prostate cancer, but majority of patients develop disease recurrence following ADT. There...